Macrophage Exosomes Induce Placental Inflammatory Cytokines: A Novel Mode of Maternal-Placental Messaging. by Holder, Beth et al.
Holder, Beth; Jones, Tessa; Shimizu, Vanessa Sancho; Rice, Thomas
F; Donaldson, Beverly; Bouqueau, Marielle; Forbes, Karen; Kamp-
mann, Beate (2016) Macrophage Exosomes Induce Placental Inflam-
matory Cytokines: A Novel Mode of Maternal-Placental Messaging.
TRAFFIC, 17 (2). pp. 168-178. ISSN 1398-9219 DOI: https://doi.org/10.1111/tra.12352
Downloaded from: http://researchonline.lshtm.ac.uk/4651961/
DOI: 10.1111/tra.12352
Usage Guidelines
Please refer to usage guidelines at http://researchonline.lshtm.ac.uk/policies.html or alterna-
tively contact researchonline@lshtm.ac.uk.
Available under license: http://creativecommons.org/licenses/by/2.5/
doi:10.1111/tra.12352
Macrophage Exosomes Induce Placental
Inﬂammatory Cytokines: A Novel Mode
of Maternal–Placental Messaging
Beth Holder1∗, Tessa Jones1, Vanessa Sancho Shimizu1,2, Thomas F. Rice1, Beverly Donaldson1,
Marielle Bouqueau1, Karen Forbes3,4 and Beate Kampmann1,5
1Section of Paediatrics, Division of Infectious Diseases, Department of Medicine, Imperial College London, London, UK
2Virology, Division of Infectious Diseases, Department of Medicine, Imperial College London, London, UK
3Division of Reproduction and Early Development, Leeds Institute of Cardiovascular and Metabolic Medicine (LICAMM), The
University of Leeds, Leeds, UK
4Maternal and Fetal Health Research Centre, Institute of Human Development, The University of Manchester, Manchester, UK
5Vaccines & Immunity Theme, MRC Unit, Banjul, The Gambia
∗Corresponding author: Beth Holder, b.holder@imperial.ac.uk
Abstract
During pregnancy, the placenta forms the interface between mother and
fetus. Highly controlled regulation of trans-placental trafﬁcking is there-
fore essential for the healthy development of the growing fetus. Extra-
cellular vesicle-mediated transfer of protein and nucleic acids from the
human placenta into the maternal circulation is well documented; the
possibility that this trafﬁcking is bi-directional has not yet been explored
but could affect placental function and impact on the fetus. We hypothe-
sized that the ability of the placenta to respond tomaternal inﬂammatory
signals is mediated by the interaction of maternal immune cell exosomes
with placental trophoblast. Utilizing the BeWo cell line and whole pla-
cental explants, we demonstrated that the human placenta internalizes
macrophage-derived exosomes in a time- and dose-dependent man-
ner. This uptake was via clathrin-dependent endocytosis. Furthermore,
macrophage exosomes induced release of proinﬂammatory cytokines
by the placenta. Taken together, our data demonstrates that exosomes
are actively transported into the human placenta and that exosomes
from activated immune cells modulate placental cytokine production.
This represents a novel mechanism by which immune cells can signal to
the placental unit, potentially facilitating responses to maternal inﬂam-
mation and infection, and thereby preventing harm to the fetus.
Keywords cytokines, endocytosis, exosomes, extracellular vesicles,
immunology, macrophage, microvesicles, placenta, pregnancy, repro-
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Exosomes are small 30–150 nm vesicles formed within
cells by inward budding of the limiting membrane of mul-
tivesicular bodies (MVBs) within the cytoplasm. Following
fusion ofMVBswith the plasmamembrane of the cell, exo-
somes are released into the extracellular space. Originally
described 30 years ago, exosomes have experienced a resur-
gence of interest in the wake of the studies implicating their
role in multiple cell–cell signalling events, particularly in
the immune system. Exosomes are released by many types
of immune cells, including macrophages, dendritic cells
and B cells (1–3) and play diverse roles, including mediat-
ing T cell activation (4,5) and maturation of dendritic cells
(6). Thus, exosomes are actively involved in immune cell
communication.
The human placenta releases a large amount of sub-cellular
vesicles into the maternal circulation, including exosomes
and the larger microvesicles. Placental microvesicles have
often been demonstrated to be pro-inflammatory (7–10),
whilst placental exosomes may be more important in
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inducing a tolerant immune response (11,12), although this
is not always the case. For example, both exosomes and
microvesicles from placenta cause immunomodulation by
altering toll-like receptor (TLR)-mediated responses of
maternal immune cells (10,13). Whilst the release of extra-
cellular vesicles from the placenta is a normal process
of pregnancy, elevated production of placental microvesi-
cles and exosomes, and their heightened pro-inflammatory
effect on maternal immune cells are both implicated in
pre-eclampsia, a disorder of pregnancy characterized by
systemic inflammation (7,14).
There is growing appreciation of the importance of
feto-placental-maternal crosstalk in establishing andmain-
taining healthy pregnancy.Whilst it is nowwidely accepted
that placenta-derived extracellular vesicles can influ-
ence the maternal immune response during pregnancy,
bi-directional trafficking between immune cells and the
placenta has yet to be explored. This is particularly impor-
tant because the placenta also mounts its own immuno-
logical responses to infection: TLRs, which recognize
and respond to pathogen-associated-molecular-patterns
(PAMPs), are present in the human placenta throughout
gestation (15,16), and stimulation of these placental TLRs
results in a robust cytokine response by trophoblast cells
(11,17). Virtually all cytokines have been detected in the
human placenta at varying levels. In addition to placen-
tal cytokine responses driven by direct infection of the
placenta (18), placental inflammatory responses can be
observed in the absence of placental infection, although
driven by signals from activated maternal cells (19,20).
Thus, the human placenta is an active immunological
organ, which can respond both to infectious agents and to
activation signals from the maternal immune system.
In light of evidence that various immune cells signal via
exosomes, and that the placenta responds to maternal
inflammatory signals, we hypothesise that the ability of
the placenta to respond to inflammation can be mediated
by uptake of immune cell exosomes. Here, we demon-
strate that human trophoblast cells take up macrophage
exosomes by an active endocytic mechanism and that
this interaction impacts on placental pro-inflammatory
cytokine production.This reveals a novelmode ofmaternal
to placental cellular messaging.
Results and Discussion
Isolation and characterization of THP-1 macrophage
exosomes
We utilized the THP-1 monocyte-derived macrophages as
a model cell line for generation of immune cell exosomes
as they can be readily differentiated into macrophages,
and release high levels of exosomes. Analysis by Nanosight
Tracking Analysis (NTA), an established model for siz-
ing/counting extracellular vesicles (21,22), demonstrated
that vesicles isolated by a sequential centrifugationmethod
had a mean size of 137.6 nM± 18.50 and mode size of
111.9± 15.09 consistent with previously demonstrated
size of exosomes (Figure 1A,B). Furthermore, isolated
vesicles were positive for both the tetraspanin CD81,
which is embedded in the exosome membrane and ALIX,
localized in the lumen of exosomes, indicating the pres-
ence of intact exosomes (Figure 1C). Calnexin, a marker
of endoplasmic reticulum, was only detectable in whole
cell extracts, demonstrating that exosome isolates were
not contaminated with cellular debris (Figure 1C). These
macrophage-derived exosomes were used in subsequent
uptake experiments.
Uptake of macrophage exosomes by human
trophoblast cells
To determine if placental trophoblast cells take up immune
cell exosomes, we initially investigated macrophage exo-
some uptake kinetics in the BeWo cell line. BeWos are a
choriocarcinoma cell line commonly used to investigate
trophoblast biology. We demonstrated dose-dependent,
time-dependent exosome uptake, with an increase in
percentage of PKH-positive BeWos by flow cytometry
(Figure 2A–C). As BeWos were trypsinized and washed
prior to flow cytometry, detectable fluorescence indi-
cates the internalization of exosomes rather than just
surface binding. Addition of unstained exosomes had no
effect (Figure 2A). Confocal microscopy further demon-
strated cellular association and uptake of PKH-labelled
macrophage exosomes into trophoblast cells (Figure 2D).
We next moved to ex vivo culture of human placental
explants, and demonstrated uptake of labelled exosomes
into organized placental tissue, as visualized by confocal
microscopy (Figure 2E, Movie S1, Supporting Informa-
tion). Uptakewas often concentrated in villous tips andwas
predominantly in the trophoblast cell layers. To rule out
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Figure 1: Isolation of exosomes
from PMA-activated THP-1 cells.
Exosomes were isolated by differential
centrifugation from THP-1 cells dif-
ferentiated to macrophages by PMA
treatment. Exosome phenotype was
assessed by Nanosight Tracking Analysis
(NTA) and western blotting for exosome
markers. A) Representative NTA his-
togram demonstrating size distribution
of exosome isolation from macrophages.
Grey error bars indicate ±1 standard
error of the mean. B) Mean and mode
size of isolated macrophage exosomes,
n= 8; C) Western blotting for negative
exosome marker calnexin and positive
exosome markers ALIX and CD81.
contamination with unbound PKH dye and non-specific
transfer to cells in these experiments, we utilized a PKH
labeling control.This control was obtained during the PKH
staining procedure by including a tube without exosomes
to which PKH dye was added. Using all methods, no
increased fluorescence was observed following incubation
with the PKH labeling control, confirming specificity
of detected exosome uptake. Vargas et al. (23) recently
reported that BeWo-derived exosomes can re-enter BeWo
cells. Our data comprise the first demonstration, to our
knowledge, of the uptake of heterologous exosomes by the
human placenta.
Exosome uptake by human trophoblast cells is an
active clathrin-dependent endocytic process
At 4 ∘C, there was complete abolition of exosome uptake
in BeWo cells (Figure 3A), demonstrating that uptake
was an active process. To determine if endocytosis was
the route of exosome entry, as previously shown in other
cell types (24,25), cells were pre-incubated with endo-
cytosis inhibitors cytochalasin D or dynasore prior to
addition of labelled exosomes. Cytochalasin D causes
de-polymerization of the actin cytoskeleton, thereby
inhibiting multiple endocytic pathways. Dynasore is a
specific small molecule inhibitor of dynamin activity
(26). Dynamin is considered a master regulator of endo-
cytosis, being required for all but some clathrin- and
caveolae-independent endocytoic uptake and has recently
shown to inhibit endocytic uptake of exosomes into
epithelial cells (27). The highest concentration of dynasore
reduced exosome uptake by 45% (p< 0·05, Figure 3B).The
highest concentration of cytochalasin D reduced uptake by
72% (p< 0·05). This demonstration of the role of endocy-
tosis in exosome uptake by the placenta is similar to studies
investigating uptake of Epstein–Barr virus (EBV)-infected
B cell exosomes by epithelial cells (27), oligodendrocyte
exosomes by microglia (28) and reticulocyte exosomes by
macrophages (29). Combination treatment with dynasore
and cytochalasin D resulted in synergistic reduction of
exosome uptake, with 84% inhibition at the highest com-
bined concentrations (Figure 3D). No effect was observed
with the carrier control, dimethyl sulfoxide (DMSO), and
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Figure 2: Uptake of macrophage exosomes by trophoblast cells. BeWos were incubated with PKH-labelled exosomes,
followed by trypsinization and ﬂow cytometry. To control for possible ﬂow-through and passive uptake of dye, a control of PKH
without exosomes was included, and added at the same volume as exosomes (PKH control/Ct). A) Representative histograms showing
% PKH-positive cells after 3 h incubation with increasing concentrations of PKH-labelled exosomes, or the highest concentration of
unlabelled exosomes (1x1010/ml; unlabelled). B) % PKH-positive cells after 3 h incubation with increasing concentrations of exosomes,
n= 4. C) % PKH-positive cells after incubation with 5× 109 exosomes for 1, 2 or 3 h, n= 5. D) Confocal microscopy of BeWos following
3 h incubation with labelled exosomes (NT, non-treated). E) Confocal microscopy term placental explants following 3 h incubation with
labelled exosomes (villous tip indicated by dotted line).
Trafﬁc 2016; 17: 168–178 171
Holder et al.
Figure 3: Active placental uptake of macrophage exosomes by clathrin-mediated endocytosis. BeWos were incubated
with 5× 109/mL PKH-labelled exosomes for 3 h, followed by trypsinization and ﬂow cytometry. A) % PKH+ BeWos following incubation
with exosomes at 37 ∘C or 4 ∘C, n= 7. B) Exosome uptake following 30min pre-treatment with endocytosis inhibitors dynasore or
cytochalasin, reported as% of exosome treatment alone (−), n= 6, B) Exosome uptake following 30min pre-treatment with endocytosis
inhibitors dynasore or cytochalasin D, reported as % of uptake in the absence of treatment, n= 6. C) Exosome uptake following 15min
pre-treatment with 25 μMPitstop 2 before addition of exosomes for 30min, reported as% of uptake in the absence of treatment, n= 5.
D) Exosome uptake following 30min pre-treatment with endocytosis inhibitors dynasore or cytochalasin D alone and in combination,
reported as % of uptake in the absence of treatment, n= 6. B,C) Percent cell viability following treatment with endocytosis inhibitors,
relative to no treatment, n= 3.
no significant change in cell viability was observed follow-
ing treatment with dynasore nor cychalasin D (Figure 3E).
This data suggests there was both dynamin-dependent and
-independent exosome uptake by placental trophoblast.
This endocytosis could be either clathrin- or calveolin-
mediated. As human syncytiotrophoblast, which covers
thematernal side of the placenta, expresses clathrin but not
caveolae (30,31), it was most likely that clathrin-mediated
rather than calveolin-mediated endocytosis was the path-
way for exosome uptake. Clathrin-mediated endocytosis
is involved in uptake of other molecules into the placenta
such as albumin and cholesterol (31,32). Using Pitstop
2, a cell-permeable clathrin inhibitor, flow cytometric
analysis showed complete abolition of exosome uptake,
demonstrating that it was indeed clathrin-dependent
(Figure 3C). Pitstop treatment resulted in a small decrease
in cell viability (Figure 3E), so for flow cytometric analy-
sis of exosome uptake, it was ensured that only live cells,
excludingDAPI, were gated.Therefore, uptake of exosomes
by the placenta occurs via clathrin-mediated endocytosis;
the receptor for this uptake is under investigation.
Macrophage exosomes induce pro-inﬂammatory
cytokine production by the placenta
Our data thus far indicates that macrophage exosomes
are actively endocytosed into placental tissue. We sought
to explore whether this interaction had any impact on
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Figure 4: Placental production of IL-6, IL-8, IL-10 and IL-12 in response to macrophage exosomes. Placental explants
were incubated with 1× 1010 –1× 1011/mL exosomes for 24 h. Supernatants were collected and cytokines assayed by ELISA. Exosomes
induced signiﬁcant increases in the production of A) IL-6 (n= 10), B) IL-8 (n= 7), C) IL-10 (n= 9) (all p< 0.0005, Friedman ANOVA), but
no increase in D) IL-12 (n= 11, p= 0.95). Asterisks above individual columns indicates a signiﬁcant difference from the non-treated
(NT), and differences between other columns are indicated by brackets (Dunn’s multiple comparisons posthoc test).
placental function. As we utilized macrophages exosomes,
this current study has particular implications for con-
veyance of signals from maternal immune cells to the
placenta. Given the macrophage origin of our exosomes,
and the ability of trophoblast to respond to inflammatory
milieu, we examined the production of cytokines by the
placenta. Initially we utilised BeWo cells, and found a sig-
nificant induction of IL-6 by macrophage exosomes (data
not shown). However, we also found that our BeWo cells
did not respond well to our positive control (1–100 ng/ml
LPS), similar to previous studies which show that, despite
expressing TLR-4, BeWos do not respond as expected to
LPS (33).Therefore, all subsequent functional experiments
were performed only in themore relevant human placental
explant model.
Following 24 h incubation with macrophage exosomes,
placental release of IL-6 was significantly increased,
with a 3·5-fold induction at the highest concentration of
1× 1011/mL exosomes (Figure 4A). Placental release of
IL-8 was also increased 2·4-fold at the highest concentra-
tion of exosomes (Figure 4B). IL-10 release was very low,
with levels often undetectable in non-treated wells; how-
ever, it followed a pattern similar to IL-6/8, with significant
increased release following incubation with macrophage
exosomes (Figure 4C). IL-12 was readily detectable in
explant supernatants, but levels were more heterogenous
than IL-6/8 and there was no change following incubation
with macrophage exosomes (Figure 4D). IFN-γ, TNF-α
and IL-17A were all undetectable in the explant super-
natants (<40 pg/mL IFN-γ, n= 5; <40 pg/mL TNF-α,
n= 12; <4 pg/mL IL-17A, n= 2). Therefore, in summary,
macrophage exosome induce placental release of IL-6, IL-8
and IL-10.
Many studies have studied placental cytokines in situ at
the mRNA and protein level, where a complete range
of cytokines are expressed (34), but less have explored
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the profiles of cytokines released from explants ex vivo.
Although the placenta contains some cytokine-producing
immune cells, the majority of cytokines released into the
maternal circulation come from the trophoblast layers.
These specialized epithelial cells have been reported to
release a cytokine repertoire similar to other epithelial
cell types, including high IL-6/IL-8 production, which
increases under inflammatory stimuli (35–38). The
increased release of IL-8 in response to macrophage exo-
somes could be important in recruiting maternal immune
cells to the maternal–foetal interface. Our results do differ
from other studies that report resting TNF-α release from
placental explants (35), which we did not observe. The
reason for this is unclear, but one factor that impacts on
placental cytokines is the mode of delivery, and whilst
our study utilized placentas from vaginal delivery, in
that study, all placentas were from caesarean sections.
Immunohistochemical measurement of in situ placental
cytokine expression, in response to immune cell exo-
somes could provide more detailed information on the
immunomodulatory effect of macrophage exosomes.
As macrophage exosomes can contain endogenous
cytokines (39), we measured the IL-6 and IL-8 levels
in our exosomes to confirm that the levels we were
measuring in supernatants were due to release from the
placenta. As seen in Figure S1, at the highest concentra-
tion of 1× 1011/mL, the exosomes contained both IL-6
(0·36 μg/mL± 0·24), and IL-8 (14·8 μg/mL± 13·3). IL-8
was surprisingly high, and could play a role in mediating
placental responses to macrophage exosomes. However,
for both cytokines, endogenous exosome levels could not
account for the levels we measured in explant-containing
wells (Figure S1). Therefore the greatly increased levels we
saw from explants following treatment with exosomes was
due to de novo cytokine release from the placenta.
Our demonstration that macrophage exosomes stimu-
late placental cytokine release is supported by previous
studies showing that exosomes derived from activated
macrophages are taken up and cause activation of naïve
recipient immune cells (3) and exosomes isolated from
body fluids activate monocytes through TLRs (40). Fur-
thermore, a series of papers from Schorey et al. have
demonstrated that macrophages infected with intra-
cellular bacteria, release exosomes containing PAMPs,
which can activate naïve macrophages and CD4/CD8
T cells in vitro and in vivo (3,41,42). Conversely, this
group found that exosomes released by cells infected with
Mycobacterium tuberculosis suppress IFN-γ-mediated
activation of naïve macrophages, helping the persistence
of infection (43). Therefore, the exosome pathway rep-
resents an additional non-cell-associated mechanism of
antigen transfer between immune cells, which can exert
varying effects on naïve cells. We therefore hypothesise
that macrophage-derived exosome entry into the pla-
centa could result in immunomodulation and alterations
in the ability of the placenta to respond to subsequent
inflammatory stimuli.
Concluding remarks
Several studies have investigated the role of placental
microvesicles and exosomes in modulation of maternal
immune cells (7,9,10,13). The converse interaction from
mother to placenta has not been explored previously,
but our data shows there is active endocytosis of het-
erologous exosomes by the human placenta. Moreover,
we demonstrate here that the placenta can respond to
these non-contact-dependent messages from activated
macrophages, via exosomes, and therefore the exosome
pathway may mediate protective placental immune
responses during pregnancy. This study thereby reveals
the proof of concept for a novel route of communica-
tion between the mother and placenta, via circulating
exosomes.
Materials and Methods
Cell culture
BeWo cells weremaintained inDMEM:F12-Glutamax supplementedwith
10% foetal calf serum (FCS) and antibiotics. THP-1 cells were main-
tained in RPMI-Glutamax supplemented with 10% FCS and antibiotics.
For differentiation into macrophage cells, THP-1 cells were seeded at
0·5–1× 106/mL with 50 ng/mL Phorbol 12-myristate 13-acetate (PMA)
for 24 h, washed and changed to newmedia to rest for 48 h before starting
exosome collection. For the exosome collection period, cells were cultured
in media supplemented with 10% exosome-depleted FBS (Exo-FBS; Sys-
tem Biosciences) for 48–72 h.
Placenta samples
Placentas were collected from healthy term pregnancies following vagi-
nal delivery or caesarean section (37–42 week). NRES ethical approval
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(13/LO/1712) and written informed consent were obtained. Villous tissue
was excised from three randomly selected areas of the placenta, washed
in sterile PBS, and dissected in DMEM/F12 (Gibco) containing 2mM
L-glutamine, 100U/mL streptomycin and 100 U/mL penicillin (GSP)
(Gibco).
Exosome preparation and quantiﬁcation
Exosomes were purified from cell culture supernatants by sequential
centrifugation; 10min at 1000 g to remove cells, 10 000× g for 10min
to remove cell debris and then exosomes were pelleted at 100 000× g
for 90min. The final pellet was resuspended in PBS or diluent C (for
PKH-staining, Sigma) and passed through a 0·2 μMfilter. Exosomes were
quantified and sized using Nanoparticle Tracking Analysis (NTA; LM10;
Nanosight) following the manufacturer’s instructions. Samples were
loaded using a syringe pump to improve accuracy. Three videos of 90 s
each were collected and batch analysed using the instrument software
(NTA 2·3).
Fluorescence labeling of exosomes
For labeling experiments, exosome pellets were resuspended directly in
diluent C from the lipophilic PKH-26 labeling kit (Sigma). Labelling was
performed following the manufacturer’s instructions, with the following
modifications for exosome labelling. To stop the reaction, 2% BSA was
used, as FBS contains endogenous exosomes. To remove unbound dye,
preparations were loaded on to a 7 kDa Zeba spin column (Pierce).
A PKH labelling control was obtained by putting a tube with diluent
alone through the PKH staining procedure. This was used in subsequent
experiments by adding the same volume as required for the concentration
of the corresponding exosome sample (designated PKH control).
Western blotting
Total protein extracts were prepared using RIPA buffer containing pro-
tease inhibitors and quantified by BCA assay (Pierce). Protein was pre-
pared in NuPage LDS buffer plus β-mercaptoethanol and heated at
95∘C for 5min. For CD81, protein was prepared in LDS buffer without
β-mercaptoethanol. Equal amounts of protein (20 μg) were separated on
Bis-Tris gels and transferred onto PVDF membrane (iBLOT gel transfer
stacks; Invitrogen). Following protein block (1% BSA/5% skimmedmilk),
membranes were probed with primary antibody followed by incubation
with HRP-conjugated secondary antibodies. Antibodies against the fol-
lowing antigens were used: CD81 (RabMab, Abcam), ALIX (RabMab,
Abcam), calnexin (Cell Signalling Technology). Secondary antibody was
from Dako (Goat anti-rabbit-HRP). Finally, membranes were developed
using ECL Prime Western blotting detection reagent (Amersham) and
Hyperfilm (Amersham).
BeWo exosome uptake assays
BeWo cells were plated on glass coverslips (for microscopy) or 12-well
cell culture plates (for flow cytometry) at 0·1× 106cells/mL and left to
adhere overnight. Cells were washed and isolated THP-1-derived exo-
somes were added to cells at 109 –1011/mL (concentration determined
by NTA) and incubated at 37∘C. To determine if the uptake of exosomes
was via an active process, cells were alternatively incubated at 4∘C. For
endocytosis inhibition, cytochalasin D (0·8–80 μM; C2618; Sigma) or
dynasore (0·1–10 μM; D7693; Sigma) were added to cells 30min before
addition of exosomes. Following the results of these experiments, com-
bination treatment with both inhibitors was also tested. The two higher
doses of both dynasore (1 μM and 10 μM) and cytochalasin D (8 μM and
80 μM)were added to cells alone and in combination, 30min before addi-
tion of exosomes. For clathrin-inhibition, cells were treated with Pitstop
2 (25 μM; Abcam) under serum-free conditions for 15min prior to exo-
some addition for a further 30min. Carrier controls were included for all
experiments.
Explant culture
Small placental villous explants (2–3mm) were dissected in serum-free
DMEM/F12 containing 2mM L-glutamine, 100U/mL streptomycin, and
100U/mL penicillin (GSP) (Gibco). Explants were placed one per well,
in a 96 well plate. To account for variation in explant size, treatments
were performed in triplicate and randomized across the plate. Isolated
exosomes were added to explants at 1010 –1011/mL. To check for endoge-
nous exosomal cytokines, exosome-only control wells were incubated at
the highest concentration alongside placental explants and included in
subsequent ELISAs. Supernatants were collected after 24 h for cytokine
analysis and explants were washed and fixed with 4% paraformaldehyde
for microscopy.
Flow cytometry
Following incubation with labelled exosomes, BeWo cells were washed,
trypsinized, washed in media containing 5mM EDTA and finally resus-
pended in FACS buffer (1% FCS, 5mM EDTA in PBS). DAPI was added
prior to acquisition for gating of viable cells. Samples were measured on
either: a Becton Dickinson FortessaLSR equipped with 20mW 355 nm,
50mW 405 nm, 50mW 488 nm, 50mW 561 nm, 20mW 633 nm lasers
and a ND1·0 filter in front of the FSC photodiode or a Becton Dickin-
son FortessaLSR equipped with 50mW 405 nm, 50mW 488 nm, 50mW
561 nm, 20mW 633 nm lasers and a ND1·0 filter in front of the FSC
photodiode. Acquisition was set to record 10 000 single cells, following
FSC-A/W, SSC-A/W gating to exclude doublets and DAPI-negative gat-
ing to exclude dead cells. PMT voltages were adjusted after standardized
CST checks minimizing the spectral overlap to increase data precision.
To detect PKH-26 fluorescence, a 561 nM laser with 582/15 nM band pass
filter was used. Analysis was performed using FlowJo.
Confocal ﬂuorescence microscopy
Following incubation with labelled exosomes, BeWo cells plated on glass
coverslips were washed 3 times with PBS, fixed in 4% paraformalde-
hyde and mounted with Prolong Gold. Placental explants were washed
and fixed before embedding in OCT, cryosectioning and mounting with
Prolong Gold. Confocal images of BeWos were acquired on a Zeiss Pas-
cal system. Confocal images of placental explants were acquired on a
Leiss LSM 510 system. Image processing was performed using the Zeiss
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LSM image browser software and NIH ImageJ (http://rsbweb. nih.gov/ij;
Open Source).
Viability assays following endocytosis inhibition
Cytotoxicity of endocytosis inhibitorswas tested using theCellTiterAque-
ous One assay according to the manufacturers instructions (Promega).
Cells were plated in duplicate in a 96 well plate at 0·1× 106/mL, 100 μL
per well and incubated overnight. Following treatment with dynasore or
cytochalasin D, 20 μL Cell Titer reagent was added to each well and the
plate incubated at 37∘C for 2 h followed by optical density measurement
at 490 nm. ODs of treated cells were compared with the non-treated cells,
expressed as percentage viability.
ELISAs
Culture supernatants were assayed for the following cytokines; IL-6,
IL-8, IL-10 and IL-17A using commercial ELISA kits (IL-6/IL-8/IL-17
Ready-SET-Go!; eBioscience, IL-10 Diaclone) and IL-12, IFN-γ and
TNF-α using in-house ELISAs (capture and biotinylated detection anti-
bodies from BD, development with OPD). Sensitivities were as follows:
2 pg/mL for IL-6, IL-8, IL-17A, 4·9 pg/mL for IL-10, and 20 pg/mL IL-12,
IFN-γ and TNF-α. For IL-10, IL-17A, IFN-γ and TNF-α, for which levels
were very low, the lowest dilutions performed were 1:2, meaning that lev-
els reported as ‘undetectable’ were those below 4 pg/mL for IL-17A and
40 pg/mL for IFN-γ and TNF-α.
Statistical analysis
Following testing for Gaussian distribution using D’Agostino–Pearson
omnibus normality test, appropriate parametric/non-parametric tests
were selected. For comparison of multiple groups, the Friedman test was
performed, with Dunn’s post hoc comparing all groups to the non-treated.
For the comparison of two groups, the Mann–Whitney U-test was used.
For inhibition experiments, Wilcoxon signed-rank test was performed,
comparing exosome uptake following treatment with inhibitors to uptake
of exosomes without drug treatment (designated as 100%). All analysis
was performed using GRAPHPAD PRISM 6.
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Movie S1: Z stack of villous tip of placental explant showing uptake of
labelled (red) exosomes into trophoblast cells (nuclei in blue).
Figure S1: Endogenous exosomal IL-6 and IL-8. Control wells of exo-
somes alone were incubated alongside placental explants at the highest
concentration, and assayed for (A) IL-6 (n= 4) and (B) IL-8 (n= 3) by
ELISA.
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